Adc Therapeutics Sa (ADCT)

08:25 AM

ADC Therapeutics Reports First Quarter 2025 Financial Results - TradingView

08:25 AM

08:00 AM

ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - PR Newswire

08:00 AM

07:56 AM

ADC Therapeutics reports high response in lymphoma trial - Investing.com

07:56 AM

07:45 AM

Breakthrough: New Cancer Drug Combo ZYNLONTA-COLUMVI Achieves 90% Complete Response in Lymphoma Trial - Stock Titan

07:45 AM

May 13, 2025

What To Expect From ADC Therapeutics SA (ADCT) Q1 2025 Earnings - GuruFocus

May 13, 2025

May 13, 2025

Wells Fargo & Company MN Increases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 13, 2025

May 12, 2025

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight - GlobeNewswire Inc.

May 12, 2025

May 12, 2025

Barclays PLC Purchases 13,756 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 12, 2025

May 09, 2025

ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 - BioSpace

May 09, 2025

May 07, 2025

JPMorgan Chase & Co. Has $74,000 Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 07, 2025

May 03, 2025

ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Monday - MarketBeat

May 03, 2025

May 03, 2025

ADC Therapeutics (ADCT) to Release Quarterly Earnings on Monday - Defense World

May 03, 2025

May 02, 2025

LPL Financial LLC Invests $50,000 in ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 02, 2025

May 01, 2025

Chondrosarcoma Market: Epidemiology, Therapies, Companies, - openPR.com

May 01, 2025

Apr 30, 2025

BlackRock, Inc. Reduces Stake in ADC Therapeutics SA - GuruFocus

Apr 30, 2025

Apr 30, 2025

Geode Capital Management LLC Acquires 9,938 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 30, 2025

Apr 28, 2025

ADC Therapeutics (ADCT) Unveils Promising Preclinical ADC Data a - GuruFocus

Apr 28, 2025

Apr 28, 2025

ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025 - BioSpace

Apr 28, 2025

Apr 28, 2025

Stock Market Recap: Adc Therapeutics SA (ADCT) Concludes at 1.41, a -5.37 Surge/Decline - DWinneX

Apr 28, 2025

Apr 28, 2025

ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

Apr 28, 2025

Apr 28, 2025

ADC Therapeutics Announces Preclinical Data Highlighted at the A - GuruFocus

Apr 28, 2025

Apr 28, 2025

ADC Therapeutics (ADCT) Unveils Promising Preclinical ADC Data at AACR 2025 | ADCT Stock News - GuruFocus

Apr 28, 2025

Apr 28, 2025

Russell Investments Group Ltd. Buys 9,248 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 28, 2025

Apr 25, 2025

ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update - Seeking Alpha

Apr 25, 2025

Apr 16, 2025

Antibody Drug Conjugate Market to Witness Upsurge in Growth - openPR.com

Apr 16, 2025

Apr 15, 2025

Wellington Management Group LLP Purchases 84,785 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 15, 2025

Apr 13, 2025

ADC Therapeutics : Announces Eight Presentations on Data from its Next-Generation Antibody Drug Conjugates at the 62nd American Society of Hematology Annual Meeting - marketscreener.com

Apr 13, 2025

Apr 13, 2025

Sei Investments Co. Invests $46,000 in ADC Therapeutics SA (NYSE:ADCT) - The AM Reporter

Apr 13, 2025

Apr 13, 2025

Sei Investments Co. Makes New $46,000 Investment in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 13, 2025

Apr 12, 2025

Prudential Financial Inc. Invests $35,000 in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Apr 12, 2025

Apr 09, 2025

Neuroendocrine tumors Pipeline Analysis and Clinical Trials - openPR.com

Apr 09, 2025

Apr 09, 2025

SEC Form PRE 14A filed by ADC Therapeutics SA - Quantisnow

Apr 09, 2025

Apr 08, 2025

HC Wainwright Lifts Earnings Estimates for ADC Therapeutics - MarketBeat

Apr 08, 2025

Apr 08, 2025

ADC Therapeutics : 24th Annual Needham Virtual Healthcare Conference - marketscreener.com

Apr 08, 2025

Apr 07, 2025

Analyzing Ratios: Adc Therapeutics SA (ADCT)’s Financial Story Unveiled - DWinneX

Apr 07, 2025

Apr 07, 2025

ADC Therapeutics SA (NYSE:ADCT) Sees Large Decline in Short Interest - MarketBeat

Apr 07, 2025

Apr 04, 2025

Research Analysts Set Expectations for ADCT Q1 Earnings - Defense World

Apr 04, 2025

Apr 04, 2025

Burkitt Lymphoma Market Expected to Witness Significant Growth by 2032 | DelveInsight - The Globe and Mail

Apr 04, 2025

Apr 04, 2025

ADC Therapeutics SA's (NYSE:ADCT) 31% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st

Apr 04, 2025

Apr 04, 2025

NBE Therapeutics opens ADC research facility in Switzerland - Pharmaceutical Technology

Apr 04, 2025

Apr 03, 2025

ADC Therapeutics' (ADCT) Buy Rating Reiterated at HC Wainwright - MarketBeat

Apr 03, 2025

Apr 03, 2025

ADC Therapeutics (NYSE:ADCT) Given New $7.00 Price Target at Guggenheim - MarketBeat

Apr 03, 2025

Apr 03, 2025

ADCT Stock Touches 52-Week Low at $1.61 Amid Market Challenges - MSN

Apr 03, 2025

Apr 03, 2025

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - The Bradford Era

Apr 03, 2025

Apr 02, 2025

ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Malaysian Reserve

Apr 02, 2025

Apr 01, 2025

ADC Therapeutics (NYSE:ADCT) Announces Quarterly Earnings Results - MarketBeat

Apr 01, 2025